MENU

The 70th Annual Meeting of the Japanese Society of Nephrology The 70th Annual Meeting of the Japanese Society of Nephrology

Call for Abstracts

The Committee of the 70th Annual Meeting of the JSN encourages abstract submission widely from overseas. All the abstracts submitted are rated and selected for presentation by the Committee.

The abstract is only submitted by online. The submission of abstracts by e-mail will NOT be considered. The abstract should be written in English.

Regular Submission
Nov. 4 (Wed), 2026 - at 2:00 p.m. JST on Dec. 23 (Wed), 2026

Regular Submission

The deadline for regular submission is scheduled at 2:00 p.m. JST on Dec. 23 (Wed), 2026.

Please select preferred presentation style, Oral or Poster, when you submit an abstract.

However, please note that the presentation style will be decided by the congress chairperson.

Please note that encore abstracts and case report abstracts will NOT be accepted.

*Presentation style

Presentation language

Presentations must be given in either Japanese or English.

On-site presentation

Presentations must be given on site by the first author.

  1. Oral presentation:Presentation and discussion at venue (8mins Presentation+ 4mins Discussion, Total 12mins)
  2. Poster presentation:Displaying poster and discussion at venue (4mins Presentation+ 2mins Discussion, Total 6mins)
【Best Abstract Awards】

All the abstracts submitted are rated by the Abstract Review Committee and the Committee honors high scored abstracts with Best abstract awards.
The awardees are to present their research in English as Oral presentations.

*Application Review Considerations

All abstracts will be reviewed according to the same criteria. Acceptance of abstracts will be determined by the 2027 Congress Chairperson based on the reviews conducted by the Abstract Review Committee appointed by the Congress Chairperson.

Please note that the Congress does not provide financial support to authors of regular submissions. Authors of accepted abstracts are responsible for all expenses associated with attending the Congress, including transportation, accommodation, and registration fees.

1. Maximum number of authors and institutions

Authors: 18 persons (including the first author)

Institutions: 10 centers

2. Limitations of number of words

Abstract Title: 50 words

Abstract Body: 250 words

Total number of words (including authors, institutions, title and abstract body): 300 words

3. COI disclosure

When submitting your abstract, please indicate any conflicts of interest related to your research or publication by checking the appropriate box.

Please refer to the detailed regulations for further information.

4. Password

You are required to create a password. The password is case-sensitive and must be 6 to 8 characters long. The password is required to view or modify your abstract.

For security reasons, your password cannot be retrieved or provided by the secretariat. Please make sure to keep a copy of your password in a secure place when submitting your abstract.

5. Receipt of Abstract / Notifying the result

Receipt of abstract will be automatically sent to the registered e-mail address. We strongly advise you to confirm the contents that you submit.

The result of review will be notified all candidates via e-mail. Please make sure to register accurate e-mail address.

6. Category of Regular Submission

We accept submission of English abstracts to regular session.

CKD
101 CKD (non-dialysis; basic)
102 CKD (non-dialysis; clinical)
103 Anemia and iron metabolism
104 Others
ESRD
201 Hemodialysis
202 Peritoneal dialysis
203 Renal transplantation
204 Apheresis
205 Others
AKI
301 AKI (basic)
302 AKI (clinical)
Glomerular / Tubulointerstitial Diseases (Primary and Secondary included DKD)
401 Primary glomerular diseases (basic)
402 Primary glomerular diseases (clinical)
403 Secondary glomerular diseases (basic)
404 Secondary glomerular diseases (clinical)
405 Tubulointerstitial diseases
406 Drug-induced kidney diseases (basic)
407 Drug-induced kidney diseases (clinical)
408 DKD (basic)
409 DKD (clinical)
410 Others
Pediatric / Genetic / Cystic / Urological Diseases
501 Pediatric nephrology
502 Genetic kidney diseases: cystic
503 Genetic kidney diseases: non-cystic
504 Urological diseases
Fluid, Electrolyte, and Acid-base / Mineral and Bone Disorders
601 Fluid, electrolytes, and acid-base disorders (basic)
602 Fluid, electrolytes, and acid-base disorders (clinical)
603 Bone and mineral diseases (basic)
604 Bone and mineral diseases (clinical)
Hypertension / Cardiovascular Diseases
701 Hypertension (basic)
702 Hypertension (clinical)
703 Cardiovascular diseases (basic)
704 Cardiovascular diseases (clinical)
Interdisciplinary Care / Community Health Care
801 Education and health guidance for CKD
802 Community Health Care
803 Laboratory medicine / AI
804 Others
Basic Science
901 Genetics/Development
902 Stem Cells/Regeneration
903 Extracellular Matrix/Fibrosis
904 Immunity/Inflammation
905 Hormone/Cell Signaling
906 Others

7. Keyword

Please state up to three keywords of your abstract. (at least one keyword is mandatory)

8. Submit, Confirm and Modify Abstracts

SSL

Non SSL
(If you cannot use cipher-text-based.)